Prostate Cancer Advisory Council 2021 Annual Report


The Florida Prostate Cancer Advisory Council (PCAC) was established in 2004 by state statute 381.911 and remains under the direction of the University of Florida Prostate Disease Center (UFPDC). The task of PCAC is to advise the governor, state surgeon general and state legislature on statewide issues regarding prostate cancer incidence and mortality as well as related health disparities for access to care and prostate cancer treatment. PCAC is a collaborative, multi-institutional and inter-disciplinary advisory body focused on a
communication platform that promotes education and awareness as well as improved detection and management of prostate cancer statewide. PCAC is required to file an annual report update to the Governor, State Surgeon General and the Florida Legislature.

Membership in the UFPDC PCAC is by appointment of the executive director of the UFPDC in consultation with the Department of Health’s Comprehensive Cancer Control Program and State Surgeon General to cover a geographically and institutionally diverse advisory council that shall consist of 9 members:

  • Two persons from prostate cancer survivor groups or cancer-related advocacy groups.
  • Four persons, one of whom is a physician licensed under chapter 458, one of whom is a physician licensed under chapter 459, one of whom is a scientist, one of whom is the executive director of the UFPDC or designee.
  • Three persons who are engaged in the practice of cancer related medical specialty from health organizations committed to cancer research and control.

To view the report in full, visit the Florida Prostate Cancer Advisory Council website at https://bit.ly/3qrBds7.


Ranked as the #32 urology program in the nation by U.S. News & World Report